Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine

Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine

The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has required rapid action to control its spread and vaccines are a fundamental solution to this pandemic. The development of rapid and reliable serological tests to monitor the antibody response to coronavirus disease v...

Full description

Bibliographic Details
Main Authors: Mohammad Said Ashenagar, Akiko Matsumoto, Hironori Sakai, Mikiko Tokiya, Megumi Hara, Yoshio Hirota
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
antibody
COVID-19
SARS-CoV-2
immunoassay tests
vaccination
Online Access:https://www.mdpi.com/2076-393X/10/4/487

Similar Items

Similar Items